Answers are grounded in this paper and cite their sources.
The transcription factor brachyury (TBXT in humans) promotes epithelial-mesenchymal transition (EMT) both during gastrulation and in cancer contexts and is widely used as a marker of nascent mesoderm. In their study, Benoit Bruneau and colleagues reveal the role of TBXT dosage in early human gastrulation. To know more about their work, we spoke to the first author, Emily Bulger, and the corresponding author, Benoit Bruneau, Professor at the Department of Pediatrics, University of California San Francisco (UCSF) and Director of the Gladstone Institute of Cardiovascular Disease.
No takes yet. Share an insight, caveat, or question.
A 2024 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: